Why cardiologists should be more interested in PAH3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA
VBWG at ACC 2018 Prof. Gomberg-Maitland gives numerous reasons why cardiologist should be interested in PAH, including updated knowledge on genetics and pathophysiology and interestingly, novel targets for therapy and different therapy strategies.
This 3-minute education provides a summary of just presented scientific data, recorded during the VBWG at ACC 2018. The objective is to provide a brief commentary and potential implications of these findings.
Mardi Gomberg-Maitland is Professor of Internal Medicine at VCU School of Medicine and Director of the RV Failure, HFpEF, and Cardio-Oncology Programs, and CoDirector of the Pulmonary Vascular Disease Program at Inova Heart and VascularInstitute. She is an expert clinician and researcher in the field of pulmonary vascular disease with a focus on pulmonary arterial hypertension.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.